The bank will raise capital through Basel III compliant additional Tier I bonds to the extent of Rs 3,500 crore and additional Tier II bonds to the extent of Rs 4,000 crore during FY24.The pharma company has received tentative approval from the US FDA for Palbociclib tablets, which are available in 75 mg, 100 mg, and 125 mg strengths.
The bank plans to raise Rs 7,500 crore through Basel III compliant bonds, including Rs 3,500 crore in additional Tier I bonds and Rs 4,000 crore in additional Tier II bonds during FY24. The pharma company has received tentative approval from the US FDA for Palbociclib tablets in various strengths.